Freeline Announces Orphan Drug Designations for FLT201 for the Treatment of Gaucher Disease

Plugin JSON Content Importer Pro not running: Check Licence! Check that a Licence is active for https://freeline.life
You might also like
Freeline Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Freeline Reports Second Quarter 2022 Financial Results and Business Highlights
Freeline Announces September 2022 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Freeline announces promotion of Romuald Corbau, Ph.D. to Chief Scientific Officer
Freeline Reports First Quarter 2021 Financial Results and Recent Business Highlights
Freeline to Present New Data on its Gaucher and Parkinson’s Disease Programs at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
Get in touch

+44 (0)1438 906870
contact@freeline.life

Follow us on our social channels